共 355 条
[1]
Connolly ES(2012)Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association Stroke 43 1711-1737
[2]
Rabinstein AA(2009)Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis Lancet Neurol 8 635-642
[3]
Carhuapoma JR(2011)Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2) Lancet Neurol 10 618-625
[4]
Derdeyn CP(2012)Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling Stroke 43 1463-1469
[5]
Dion J(2014)Controversies and evolving new mechanisms in subarachnoid hemorrhage Prog Neurobiol 115 64-91
[6]
Higashida RT(2015)Early events after aneurysmal subarachnoid hemorrhage Acta Neurochir Suppl 120 23-28
[7]
Hoh BL(2015)Inflammasomes: mechanism of action, role in disease, and therapeutics Nat Med 21 677-687
[8]
Kirkness CJ(2017)A brain in flame; do inflammasomes and pyroptosis influence stroke pathology? Brain Pathol 27 205-212
[9]
Naidech AM(2016)Minocycline protects against NLRP3 inflammasome-induced inflammation and P53-associated apoptosis in early brain injury after subarachnoid hemorrhage Mol Neurobiol 53 2668-2678
[10]
Ogilvy CS(2016)Melatonin attenuated early brain injury induced by subarachnoid hemorrhage via regulating NLRP3 inflammasome and apoptosis signaling J Pineal Res 60 253-262